Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 8 | 2024 | 490 | 1.770 |
Why?
|
| Wnt Signaling Pathway | 2 | 2020 | 170 | 0.640 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 164 | 0.590 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 233 | 0.560 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 4 | 2023 | 90 | 0.540 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2022 | 69 | 0.500 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 2061 | 0.450 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2023 | 759 | 0.410 |
Why?
|
| Phthalazines | 2 | 2019 | 41 | 0.320 |
Why?
|
| Hedgehog Proteins | 2 | 2022 | 188 | 0.310 |
Why?
|
| Piperazines | 2 | 2019 | 342 | 0.270 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 3215 | 0.220 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2023 | 17 | 0.210 |
Why?
|
| Transcription Factor AP-1 | 1 | 2023 | 85 | 0.200 |
Why?
|
| Semaphorins | 1 | 2022 | 28 | 0.200 |
Why?
|
| Epoxy Compounds | 1 | 2020 | 32 | 0.170 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2020 | 45 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 1356 | 0.160 |
Why?
|
| Genomics | 1 | 2024 | 716 | 0.160 |
Why?
|
| Metabolomics | 1 | 2024 | 652 | 0.160 |
Why?
|
| Histocompatibility Antigens | 1 | 2019 | 107 | 0.160 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2019 | 94 | 0.160 |
Why?
|
| Proteomics | 1 | 2024 | 1062 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 125 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 610 | 0.140 |
Why?
|
| Neuropilin-1 | 1 | 2017 | 9 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2020 | 427 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2020 | 840 | 0.130 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 67 | 0.130 |
Why?
|
| Disease Progression | 2 | 2020 | 2635 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 663 | 0.100 |
Why?
|
| Female | 8 | 2024 | 68777 | 0.100 |
Why?
|
| Models, Biological | 1 | 2017 | 1722 | 0.080 |
Why?
|
| Humans | 9 | 2024 | 129652 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 814 | 0.070 |
Why?
|
| Histones | 2 | 2023 | 588 | 0.060 |
Why?
|
| Mice | 5 | 2022 | 16937 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2017 | 4925 | 0.050 |
Why?
|
| Neuropilins | 1 | 2022 | 1 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2022 | 81 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 277 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2022 | 173 | 0.050 |
Why?
|
| Animals | 5 | 2022 | 35361 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 634 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 599 | 0.040 |
Why?
|
| Anoikis | 1 | 2020 | 31 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 315 | 0.040 |
Why?
|
| Indazoles | 1 | 2019 | 65 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 131 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 285 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 570 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 887 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2022 | 743 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1181 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 587 | 0.040 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2017 | 4 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 345 | 0.040 |
Why?
|
| Piperidines | 1 | 2019 | 199 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 429 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 141 | 0.030 |
Why?
|
| COS Cells | 1 | 2017 | 185 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2017 | 213 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 298 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 139 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2017 | 267 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 226 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 964 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 1033 | 0.030 |
Why?
|
| Indoles | 1 | 2019 | 387 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 716 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 385 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 428 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 643 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 1651 | 0.030 |
Why?
|
| Prognosis | 1 | 2022 | 3794 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 692 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1706 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 4083 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 3717 | 0.020 |
Why?
|